ATB Capital Issues Pessimistic Forecast for Aurora Cannabis (TSE:ACB) Stock Price

Aurora Cannabis (TSE:ACB) had its target price cut by investment analysts at ATB Capital from C$11.00 to C$8.50 in a research note issued on Tuesday,BayStreet.CA reports. ATB Capital’s price objective indicates a potential upside of 39.12% from the company’s previous close.

Separately, TD Securities raised Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th. Three equities research analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of C$5.85.

Aurora Cannabis Stock Down 4.8 %

Aurora Cannabis stock opened at C$6.11 on Tuesday. The company has a quick ratio of 2.48, a current ratio of 3.76 and a debt-to-equity ratio of 16.95. The company has a market capitalization of C$333.97 million, a P/E ratio of -9.70 and a beta of 2.71. The firm has a 50 day moving average price of C$6.92 and a 200-day moving average price of C$7.57. Aurora Cannabis has a twelve month low of C$3.84 and a twelve month high of C$12.85.

Insider Activity

In related news, Senior Officer Andre Jerome sold 7,712 shares of the stock in a transaction dated Monday, September 23rd. The stock was sold at an average price of C$7.70, for a total transaction of C$59,382.40.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.